Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at email@example.com if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
Posted 09 December 2013 | By Louise Zornoza,
Brazil's national regulatory agency, Anvisa, has unveiled a new database that will gather information on adverse events relating to blood products, tissues, cells and organs.
The database, which was developed by Italy's National Transplant Center, already includes more than 900 adverse event reports related to cell therapies, organ donations, and assisted reproduction, among others.
The database was first unveiled at the World Health Organization's (WHO) Third Global Meeting on Biomonitoring held in Brazil from December 7 to 9, which brought together an international group of health authorities, regulators, members of national centers on disease control and epidemiology, scientific associations, and Medical Products of Human Origin (MPHO) professionals.
Read all Breaking News from RegLink
Tags: HCT/Ps, Adverse Event, Blood Products, brazil
Regulatory Focus newsletters
All the biggest regulatory news and happenings.